CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
19,12Â USD
arrow_downward
−0,21%(−0,040) 1 D
19,12Â USD
0,00% (0,00)
bedtimeEtter stengetid
Stengt: 12. okt., 16:00:00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CHGCY …
Ã…pne
19,22Â USD
Høy
19,25Â USD
Lav
18,94Â USD
Markedsverdi
10,36Â bill.
Snittvolum
304,28k
Volum
278,74k
52 u høy
34,84Â USD
52Â u lav
18,94Â USD
Beta
0,56
Utestående aksjer
3,36Â mrd.
Antall ansatte
5k
Ã…pne
19,22Â USD
Høy
19,25Â USD
Lav
18,94Â USD
Markedsverdi
10,36Â bill.
Snittvolum
304,28k
Volum
278,74k
52 u høy
34,84Â USD
52Â u lav
18,94Â USD
Beta
0,56
Utestående aksjer
3,36Â mrd.
Antall ansatte
5k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 12 minutter siden
Chugai Pharmaceutical reports Week 52 vamikibart data: stock pre-market at EUR 34.84
Profil
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Om Chugai Pharmaceutical ADR
Administrerende direktørOsamu Okuda
Ansatte5,1k
Grunnlagt10. mars 1925
Hovedkontor-
Sektor-
Nettstedchugai-pharm.co.jp